- $13.70m
- $40.82m
- $13.79m
- 56
- 75
- 92
- 88
Annual balance sheet for Biotricity, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 2.2 | 12.1 | 0.57 | 0.786 | 0.365 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.85 | 2.41 | 1.81 | 1.81 | 2.72 |
| Total Inventory | |||||
| Total Current Assets | 4.32 | 15.3 | 4.72 | 4.47 | 4.64 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.066 | 1.27 | 1.61 | 1.24 | 0.822 |
| Long Term Notes Receivable | |||||
| Total Assets | 4.44 | 16.7 | 6.51 | 5.94 | 5.64 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.5 | 4.87 | 11.2 | 22.7 | 20.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.3 | 18.8 | 26.4 | 35.9 | 35.7 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -6.83 | -2.14 | -19.8 | -30 | -30 |
| Total Liabilities & Shareholders' Equity | 4.44 | 16.7 | 6.51 | 5.94 | 5.64 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |